Call 1-855-727-6274 or Fax 1-844-727-6274

Home

Call Us

Making a REAL difference in people’s lives

The Otsuka Patient Assistance Foundation, Inc. (OPAF) is a 501c(3) nonprofit organization that provides eligible uninsured or underinsured patients with prescribed Otsuka medication free of cost.

The OPAF mission is to improve the health & wellness for eligible patients by reducing barriers to healthy living and enabling patients along their health journeys.

Read more about opaf
people

Call 1-855-727-6274 or fax 1-844-727-6274

For assistance, please contact a dedicated Patient Access Advocate at 1-855-727-6274 (Monday-Friday 8am to 8pm ET, excluding National Holidays).

U.S.Based Healthcare Professionals (HCPS)

You can complete applications on behalf of patients with access barriers or those who are uninsured or underinsured. Apply online through the OPAF Care Connect Portal.

Apply online

When you sign up for the OPAF Care Connect Portal, you can:

  • Submit OPAF applications online. You’ll receive eligibility determination within 48 hours of completing and submitting all supporting documentation.
  • Prescription order submission and tracking for:
    • ABILIFY MAINTENA® (aripiprazole) extended release injectable suspension
    • JYNARQUE® (tolvaptan) tablets
    • REXULTI® (brexpiprazole) tablets
    • SAMSCA® (tolvaptan) tablets
  • Access prescription template for e-prescribing.
  • Submit prescriptions to our contracted pharmacy: Eversana Life Science Services

For states that require eScribe, please submit a prescription via your EMR system to:

Eversana Life Science Services, 17877 Chesterfield Airport Road, Chesterfield, MO 63005.
Phone: 1-855-727-6274
Fax: 1-844-727-6274
Hours: Monday to Friday, 8am to 8pm ET.

See U.S. FULL PRESCRIBING INFORMATION for NUEDEXTA.
See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for ABILIFY MAINTENA, ABILIFY ASIMTUFII, JYNARQUE, REXULTI, and SAMSCA.
See MEDICATION GUIDES for ABILIFY MAINTENA, ABILIFY ASIMTUFII, JYNARQUE, REXULTI, and SAMSCA.

When you sign up for the OPAF Care Connect Portal, you can
  • Submit OPAF applications online. You’ll receive eligibility determination within 48 hours of completing and submitting all supporting documentation.
  • Prescription order submission and tracking for:
    • ABILIFY MAINTENA® (aripiprazole) extended release injectable suspension
    • JYNARQUE® (tolvaptan) tablets
    • REXULTI® (brexpiprazole) tablets
    • SAMSCA® (tolvaptan) tablets
  • Access prescription template for e-prescribing.
  • Submit prescriptions to our contracted pharmacy: Eversana Life Science Services

For states that require eScribe, please submit a prescription via your EMR system to:

Eversana Life Science Services, 17877 Chesterfield Airport Road, Chesterfield, MO 63005.
Phone: 1-855-727-6274
Fax: 1-844-727-6274
Hours: Monday to Friday, 8am to 8pm ET.

Based healthcare doctors

See U.S. FULL PRESCRIBING INFORMATION for NUEDEXTA.
See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for ABILIFY MAINTENA, ABILIFY ASIMTUFII, JYNARQUE, REXULTI, and SAMSCA.
See MEDICATION GUIDES for ABILIFY MAINTENA, ABILIFY ASIMTUFII, JYNARQUE, REXULTI, and SAMSCA.

Enrollment Application for ABILIFY MAINTENA® (aripiprazole) extended-release injectable suspension

Download

Enrollment Application for ABILIFY ASIMTUFII® (aripiprazole) extended-release injectable suspension

Download

Enrollment Application for REXULTI® (brexpiprazole) tablets

Download

Enrollment Application for NUEDEXTA® (dextromethorphan HBr and quinidine sulfate) capsules

Download

Enrollment Application for SAMSCA® (tolvaptan) tablets

Download

Enrollment Application for JYNARQUE® (tolvaptan) tablets

Download

Enrollment Application for ABILIFY MAINTENA® (aripiprazole) extended-release injectable suspension

Download

Enrollment Application for ABILIFY ASIMTUFII® (aripiprazole) extended-release injectable suspension

Download

Enrollment Application for REXULTI® (brexpiprazole) tablets

Download

Enrollment Application for NUEDEXTA® (dextromethorphan HBr and quinidine sulfate) capsules

Download

Enrollment Application for SAMSCA® (tolvaptan) tablets

Download

Enrollment Application for JYNARQUE® (tolvaptan) tablets

Download
Based healthcare doctors
Patients
Patients image

Patients

We encourage you to apply and let a dedicated Patient Access Advocate do an in-depth eligibility analysis for you. You can contact a dedicated Patient Access Advocate at 1-855-727-6274 (Monday-Friday 8am to 8pm ET, excluding National Holidays) with questions.

CHECK ELIGIBILITY

OR

Frequently Asked Questions
Frequently Asked Questions image

Frequently Asked Questions

If the Eligibility tool indicates that I may be eligible, can I submit an application?

Yes, you can begin the application process by applying via the OPAF Care Connect Patient Portal. The OPAF team will work with your healthcare professional [HCP] to finish the application process. When submitting your information into the portal, please be sure to upload all of the required documentation such as income verification, U.S. home address verification, and insurance denial information.

GET ANSWERS TO OTHER FAQ

Have questions about OPAF and don’t have time for a phone call?

Send a secure message directly to a dedicated OPAF Patient Access Advocate.

SEND A SECURE MESSAGE

Supported Medications

OPAF provides eligible patients no-cost support for the following prescribed medications:

Abilify Maintena logo
Abilify Asimtufii logo
nuedexta logo
jynarque logo
rexulti logo
samsca logo

See U.S. FULL PRESCRIBING INFORMATION for NUEDEXTA.
See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for ABILIFY MAINTENA, ABILIFY ASIMTUFII, JYNARQUE, REXULTI, and SAMSCA.
See MEDICATION GUIDES for ABILIFY MAINTENA, ABILIFY ASIMTUFII, JYNARQUE, REXULTI, and SAMSCA.

To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at
1-800-438-9927 or FDA at 1-800-FDA-1088 (www.fda.gov/medwatch).

Otsuka America Pharmaceutical, Inc. does not control or influence how Otsuka Patient Assistance Foundation, Inc. distributes funds.

Secure Messaging

Secure messaging ensures patient privacy because it is a HIPAA-compliant, password-protected electronic messaging platform. You can communicate directly with an OPAF Patient Access Advocate without having to pick up the phone. Through the platform you can securely send electronic messages with any questions, communications, and documents at your convenience.

Because it is HIPAA-compliant, there is a one-time account activation process. The activation process takes less than 3 minutes. Once your account is active, you can send messages to OPAF immediately.

To setup your OPAF secure message account follow the steps below:

  • Click on the (button or envelope) below to start the process
  • The system will prompt you to enter your email address as a "New to SecureContact"
  • A verification email will be sent to the email address that you entered
  • In your email inbox, you will find a message from "[email protected]"
  • Open this message and click on the link to activate your account
  • Complete the account activation by creating a password
  • Your account is active, and you can securely send a message to OPAF

If you have any questions, please contact OPAF at 1-855-727-6274 8:00 AM - 8:00 PM ET.

MESSAGE US

message

Welcome to the Otsuka Patient Assistance Foundation, Inc.

OTSUKA logo

IMPORTANT MESSAGE  
FROM  
THE OTSUKA PATIENT ASSISTANCE FOUNDATION, INC.

Per federal regulations, patients with government issued insurance such as Medicaid and Medicare that are, also, enrolled with the Otsuka Patient Assistance Foundation, Inc. (OPAF) for free medications, will have their OPAF enrollment end on December 31st, 2024. On November 15th, 2024, an OPAF 2025 application packet will be mailed to currently enrolled Medicare and Medicaid patients. Once an OPAF application has been submitted, our dedicated Patient Access Advocates will review and provide an enrollment determination on or after January 2nd, 2025. Please ensure to submit a completed application with all supporting documentation.

If you have any questions, you may contact us at 1-855-727-6274 Monday-Friday 8 AM-8 PM EST or You may send a SECURE MESSAGE by using the “Message Us” red icon below. OPAF’s secure message platform is password protected and HIPAA compliant. Your message will be received, and our Patient Access Advocates will respond shortly.

During this time, OPAF may experience higher call volumes, which may result in longer wait times. Please have patience as we help everyone needing OPAF assistance.

November 2024    PAUS24EUC0155